Ticker: ACRS

Company: Aclaris Therapeutics, Inc.

Person: Anand Mehra, director

Transaction date: Nov. 19, 2024

Reporting date: Nov. 20, 2024

Average share price: 2.25

Bought 666666.0 shares for 1499998.5